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Background: Photoreceptor cell death due to extensive light exposure and induced
oxidative-stress are associated with retinal degeneration. A correlated dysregulation
of the complement system amplifies the damaging effects, but the local and time-
dependent progression of this mechanism is not thoroughly understood.
Methods: Light-induced photoreceptor damage (LD) was induced in Balb/c mice
with white light illumination either for 24 h with 1000 lux (constant model) or 0.5 h
with 5000 lux (acute model). Complement protein and mRNA expression levels were
compared at 1 and 3 days post-LD for C1s, complement factor B (CFB), mannose
binding lectin A, mannose-binding protein-associated serine protease 1 (MASP-1), C3,
C4, C9, and complement factor P in retina and RPE/choroid. Histological analyses
visualized apoptosis, microglia/macrophage migration, gliosis and deposition of the
complement activation marker C3d. Systemic anaphylatoxin serum concentrations were
determined using an ELISA.
Results: Apoptosis, gliosis and microglia/macrophage migration into the outer nuclear
layer showed similar patterns in both models. Local complement factor expression
revealed an early upregulation of complement factor mRNA in the acute and constant
light regimen at 1 day post-treatment for c1s, cfb, masp-1, c3, c4 and c9 in the
RPE/choroid. However, intraretinal complement mRNA expression for c1s, cfb, c3
and c4 was increased at 1 day in the constant and at 3 days in the acute model.
A corresponding regulation on protein level in the retina following both LD models was
observed for C3, which was upregulated at 1 day and correlated with increased C3d
staining in the ganglion cell layer and at the RPE. In the RPE/choroid C1s-complex
protein detection was increased at 3 days after LD irrespectively of the light intensities
used.
Conclusion: LD in mouse eyes is correlated with local complement activity. The
time-dependent local progression of complement regulation on mRNA and protein
levels were equivalent in the acute and constant LD model, except for the intraretinal,
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time-dependent mRNA expression. Knowing the relative time courses of local
complement expression and cellular activity can help to elucidate novel therapeutic
options in retinal degeneration indicating at which time point of disease complement
has to be rebalanced.
Keywords: light-induced photoreceptor degeneration, complement system, retina, RPE/choroid, C3
INTRODUCTION
Exposure to sunlight has been suggested years ago as a
risk factor for the development and progression of retinal
degeneration and particularly age-related macular degeneration
(AMD) [reviewed in Sui et al. (2013)]. Extensive light
exposure induces apoptosis-driven photoreceptor loss in humans
and mice (Wenzel et al., 2005; Organisciak and Vaughan,
2010). This is dependent on light intensity, light quality
and exposure time (Wenzel et al., 2005). Several mechanisms
are correlated with light-induced photoreceptor degeneration
(LD), including an altered retinoid metabolism, increased
oxidative stress and immunoreactions (Maeda et al., 2009; Pujol-
Lereis et al., 2016). The exact interplay of these cascaded
events still needs to be deciphered. Time-dependent analysis
of the transcriptome after LD in mice revealed a clustered
gene expression which imply a strongly regulated temporal
coordination of stress gene expression in the light-damaged
retina (Choi et al., 2001). However, we still lack an accurate
understanding of the functional relevance of this time-
dependent gene expression following LD and data that
reveal how the transcriptomics are translated into protein
expression.
The aim of the present study was to identify a LD-dependent
transcriptional and protein expression profile of components
of the complement system. Complement involvement in LD
had been shown in a wide spectrum of white light treatment
models, including mice/rats which were illuminated with light
intensities between 1000 and 10000 lux for 1 h–10 days and
evaluated after a recovery time up to 7 days (Rohrer et al.,
2007; Rutar et al., 2011; Hadziahmetovic et al., 2012; Song
et al., 2012). Comparison and generalization of these studies is
difficult. Especially, since we know, that different light intensities,
low and bright light, induce different apoptotic pathways in
the retina (Roca et al., 2004) and prolonged recovery times
influence the number of apoptotic cells following LD (Zhang
et al., 2005; Jiao et al., 2015). Therefore, we chose a short-term,
acute (0.5 h) and an intermediate, constant (24 h) exposure
time with high (5000 lux) and medium (1000 lux) white light
intensities to compare the effects of illumination on complement
factor expression after 1 and 3 days of treatment (Supplementary
Figures S1A–C).
The complement system is a humoral part of the innate
immune system which bridges the adaptive and innate
Abbreviations: CFB, complement factor B; CFP, complement factor P; ELISA,
enzyme linked immunosorbent assay; LD, light-induced photoreceptor damage;
MASP-1, mannose-binding protein-associated serine protease 1; MBL-A, mannose
binding lectin A; ONL, outer nuclear layer; RPE, retinal pigmented epithelium;
TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
immune response. Genetic polymorphisms in the complement
cascade, complement depositions in drusen and drugs
targeting factors of the complement system as potential
AMD-therapeutics, supposed a connection between retinal
degeneration, complement expression and light irradiation
(Anderson et al., 2010; Weber et al., 2014; Volz and Pauly,
2015). The complement system is composed of over 40
interacting proteins which are successively involved in
the reaction. The cascade is activated by three distinct
pathways: the classical, lectin and alternative pathways.
Activation of all three pathways results in the cleavage
of complement component C3 to C3a and C3b, with the
latter being required for the cleavage of C5 to C5a and
C5b as well as the formation of the terminal complement
complex. The complement system finally results in three main
biological functions: tagging of cell waste and pathogens by
opsonins (e.g., iC3b), attraction and activation of immune
cells by anaphylatoxins (e.g., C3a, C5a) and cell lysis by
the terminal complement complex (C5b-C9). The activity
of the complement system is tightly controlled under
physiological conditions, but it can be dysregulated in
pathological events resulting in an autoreactive damage of
cells.
Previous studies reported that c1q/s, c2, c3 and c4 mRNA
expression was upregulated in the retina after LD (Lohr et al.,
2006; Rohrer et al., 2007; Rutar et al., 2011; Hadziahmetovic
et al., 2012; Song et al., 2012), which was associated with
microglia/macrophage migration (Rutar et al., 2011) and
complement activated cell lysis (Lohr et al., 2006). Complement
reaction after light treatment had been also suggested as an
important pathway as complement factor D deficient mice were
protected from LD (Rohrer et al., 2007).
To obtain a conclusive picture, here we correlate the time-
dependent glial activation pattern, neuronal cell loss and
expression of different complement factors on mRNA and,
importantly, on protein level in the retina and RPE/choroid.
Our results confirm previously described expression patterns
regarding c1s, c3 and c4 and we added analyses regarding
cfb, masp-1, mbl-a, c9 and cfp. We describe an early gene
upregulation in the RPE/choroid after 1 day of LD in both
tested light models and in the retina for the constant light
regime. Complement gene expression showed a delayed increase
in the retina at 3 days following acute LD. We report for the
first time, that C3 and C1s were altered on protein level in
Western blots following both constant and acute LD either
in the retina or in the RPE/choroid, respectively. Overall
the studies revealed that C3, C1s and C9 could serve as
time-dependent marker proteins for complement involvement
for LD in mice.
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MATERIALS AND METHODS
Animals, Ethics Statement, and LD
Six to nine week old BALB/c mice obtained from Charles
River Laboratories (Wilmington, MA, United States) and tested
homozygous for the L450 variant of RPE65 (Wenzel et al., 2001)
were kept in cyclic light (12 h on/12 h off, lights on at 7 am,
light intensity approx. 400 lux) (Supplementary Figures S1A–
C). Mouse experiments were strictly performed according to the
guidelines of replacement, refinement, and reduction of animals
in research (Russell and Burch, 1959) and approved by the
committee on the ethics of animal experiments of the regional
agency for animal health Regierung der Oberpfalz, Veterinärwesen
(54-2532.1-04/11). To induce LD in mice, they were transferred
to cyclic dim light (<100 lux) for 5 days and followed by dark-
adapted period of 18 h. As the severity of retinal phototoxicity
in rodents depends on the circadian rhythm (Vaughan et al.,
2002) the light damage experiments were always performed in
the early morning according to previously described protocols
(Braunger et al., 2013a; Boneva et al., 2016). Briefly, mice were
isolated placed in reflective cages and exposed to diffuse cool,
white fluorescent light coming from the top of the cage for the
constant LD model with an intensity of 1000 lux for 24 h and for
the acute LD model with 5000 lux for 0.5 h. The average light
intensity was measured on the cage floor. After light exposure,
mice were allowed to recover first for 6 h in dim light, and then
brought back to normal cyclic light conditions until sacrifice. The
effects of LD were evaluated 1 and 3 days after light exposure
(Supplementary Figures S1A–C).
Antibodies
Used antibodies are listed in Supplementary Table S1. The
polyclonal anti-mouse CFP serum was generated by sequential
immunizations of rats with recombinant murine CFP as
described previously (Pauly et al., 2014).
Terminal dUTP Transferase Mediated
Nicked-End Labeling (TUNEL)
Apoptotic cell death was analyzed by TUNEL labeling using
the Apoptosis Detection System (DeadEnd Fluorometric
TUNEL, Promega). The light exposed and control retinae were
investigated following manufacturers’ instructions and protocols
published previously (Braunger et al., 2013b, 2015; Kugler et al.,
2015). For quantitative analysis, the number of TUNEL-positive
nuclei in mid-horizontal sections throughout the entire retina
was counted and normalized to the area of the ONL. Indicating
ONL cell density DAPI-positive cells were counted within central
retina (100 µm area).
Gene Expression Analyses
One eye from each animal was enucleated and hemisected for
total RNA extraction. To this end, RPE/choroid and retina
were removed from eyecups and immediately deposited in
RNA stabilizer (RNAlater, Qiagen, Hamburg, Germany). RNA
was isolated using Nucleospin RNA/Protein Kit (Macherey-
Nagel, Düren, Germany) and reverse-transcribed to cDNA
using QuantiTect Reverse Transcription Kit (Qiagen, Hamburg,
Germany) according to the manufacturer’s protocol. Mouse liver
cDNA was prepared equally.
PCR was performed to validate mouse complement gene-
specific primer pairs (Supplementary Table S2) using the
following conditions: 94◦C for 30 s, 60◦C for 30 s, 72◦C for
30 s, 33 cycles. Amplification products were analyzed using 2%
agarose gels (Supplementary Figure S2), fluorescent bands were
excised and amplified cDNA was purified after manufacturer’s
instructions (Nucleospin PCR and Gel Clean-up Kit, Macherey-
Nagel, Düren, Germany). GeneArt (Thermo Fisher Scientific,
Braunschweig, Germany) performed sequencing of amplicons
(Supplementary Table S2).
Quantitative real-time PCR (qRT-PCR) was performed on a
Rotor-Gene Q PCR cycler (Qiagen, Hamburg, Germany) using
mouse gene-specific primer pairs (Supplementary Table S2) and
Rotor Gene Sybr green PCR Kit (95◦C for 5 min, 40 cycle with
95◦C for 5 s and 60◦C for 10 s; Qiagen, Hamburg, Germany).
A relative gene expression was calculated using mRNA levels of
actin as a housekeeper with the1CT method (1CT= CT gene of
interest - CT actin) (Table 1) for normalization as well as with the
2−11CT method [fold change = 2−(1CT treated−1CT untreated)]
for comparison of treated and untreated mice (Figures 2, 3 and
Supplementary Figures S1, S3; Schmittgen and Livak, 2008).
Western Blot
Protein isolation of RPE/choroid and retina (one eye from
each animal) was performed with Nucleospin RNA/Protein Kit
(Macherey-Nagel, Düren, Germany). Samples were separated on
a reducing 10% SDS-PAGE and transferred onto polyvinylidene
difluoride membranes. Membranes were soaked in blocking
solution [5% BSA/PBS-T (PBS, 0.1% Tween 20), 1 h] and
subsequently incubated with primary antibodies diluted in
blocking solution (Supplementary Table S1, overnight, 4◦C).
After washing steps, membranes were treated with detection
antibodies diluted in blocking solution (Supplementary Table S1,
1 h) and developed with Lumi-Light blotting substrate (Roche
Diagnostics GmbH, Mannheim, Germany) or WesternSure
PREMIUM Chemiluminescent Substrate (LI-COR, Bad
Homburg, Germany).
Immunostainings
Retinae were immersion-fixed (4% paraformaldehyde, 4 h) and
embedded in paraffin. Six micrometer thick sections were used.
For epitope retrieval paraffin sections were deparaffinized and
heated in citrate-buffer pH 6 (1 h in a steamer, #ZUC028-
500, Zytomed, Berlin, Germany). For C3d and glial fibrillary
acidic protein (GFAP) analysis unspecific bindings were blocked
(30 min, #ZUC007-100, Zytomed, Berlin, Germany) and primary
antibodies were incubated overnight at 4◦C in antibody diluent
(#ZUC025-500, Zytomed, Berlin, Germany). Sections were
washed (0.1% Tween 20/PBS) and incubated with secondary
antibodies in antibody diluent (50 min). Cell nuclei were labeled
with DAPI/Hoechst 33342 (1:1000; #H1399, Thermo Fisher
Scientific, Braunschweig, Germany). After several washes (0.1%
Tween 20/PBS, PBS) the slices were embedded in fluorescent
mounting medium (#S302380-2, Dako, Glostrup, Denmark).
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For the staining of the ionized calcium binding adaptor
molecule 1 (Iba-1) we used the Zytochem Plus AP Polymer
Kit (#POLAP-006, Zytomed, Berlin, Germany) according to
the manufacturer’s protocol. Brief, sections were blocked with
3% H2O2 (10 min) and blocking solution (10 min). Primary
antibody and DAPI/Hoechst 33342 were incubated in antibody
solution (4 h). Detection was performed using AP-polymer-rabbit
(1 h) and permanent AP red (#ZUC001-125, Zytomed, Berlin,
Germany). Every incubation step was followed by washing (0.1%
Tween20/PBS). For C5b-C9 staining, the sections were blocked
with 5% bovine serum albumin (BSA, Roth Karlsruhe, Germany)
in 0.1 M phosphate buffer (1 h) and incubated with anti-C5b-C9
in blocking solution (4◦C overnight). Detection was performed
using a biotinylated anti-rabbit IgG, Alexa 488 conjugated
streptavidin and DAPI counterstaining in fluorescent mounting
medium. Images were acquired using confocal microscopy
(VisiScope, Visitron System, Puchheim, Germany).
C3a/C5a ELISA
Systemic complement activation was analyzed in serum.
Maxisorp microtiter plates (Nalgene Nunc, Penfield, NY, United
States) were coated with anti-mouse C3a and anti-mouse C5a
(phosphate buffer pH 6.5 (C3a) or carbonate buffer pH 9.5
(C5a), 4◦C, overnight) (Supplementary Table S1), respectively.
After blocking [2% skim milk in PBS-T (C3a) or 10% FCS in
PBS (C5a), 1 h], mouse sera (1:5–1:50), native mouse C3a and
recombinant mouse C5a (for the standard curve 1–100 ng/mL,
BD Bioscience) in sample buffer [0.1 mg/mL Nafamostat
Mesylate (Futhan, TCI, Eschborn, Germany), 10 mM EDTA in
PBS] were incubated (2 h). Each incubation step was followed
by three consecutive washing steps (PBS-T). Detection was
performed with anti-mouse C3a-biotin- and anti-mouse C5a-
biotin-antibody (PBS, 1 h) (Supplementary Table S1) and a final
incubation with streptavidin-HRP (1:5000 in PBS). Signal was
developed using 3,3′,5,5′-tetramethylbenzidine (TMB, Seramun
Diagnostica GmbH, Heidesee/Wolzig, Germany). Optical density
(absorption) was measured at 450 nm.
Software and Statistical Analysis
Data were statistically analyzed using GraphPad Prism 5
(GraphPad Software, San Diego, CA, United States). Western blot
and microscopy pictures were evaluated using ImageJ (Schneider
et al., 2012).
RESULTS
Light-Treatment Caused Damage in the
Retina
Photoreceptor cell death is a hallmark in LD (Grimm and
Remé, 2013). In order to determine whether constant (1000 lux,
24 h) or acute (5000 lux, 0.5 h) white light treatment differ
in the progression of LD, we counted TUNEL-positive cells
indicating apoptosis (Figures 1A–F), and DAPI-positive cell
nuclei (Figures 1A–E,G), displaying photoreceptor density in
the ONL. Cell apoptosis occurred in the ONL of mice treated
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FIGURE 1 | Cell death occurs in the ONL 1 day post-light treatment. Detection of cell death in retinae of mice either treated with (A,B) 1000 lux (24 h) or (D,E)
5000 lux (0.5 h) was performed by TUNEL- (green) and DAPI-staining (dark blue) of cell nuclei. (C) Untreated, Balb/c mice did not show TUNEL-positive cells in the
retina. Albino mice treated with light showed apoptotic TUNEL positive cells (green) in the ONL (A,D) 1 day and (B,E) 3 days after light exposure. There was a
significant increase in numbers of (F) TUNEL positive cells and a significant decrease in numbers of (G) DAPI positive cells following light exposure, however, no
significant differences in the numbers of (F) TUNEL- and (G) DAPI-positive cells regarding the light treatment regimen was observed. Scale bars, 200 µm.
∗0.01 < P < 0.05, ∗∗0.001 < P < 0.01 (ordinary one-way ANOVA, Dunnett’s multiple comparisons test, with a single pooled variance) ON, optic nerve; OS, ora
serrata.
with white light (Figures 1A–F) irrespective of the light
intensities. TUNEL-positive cells were observed in the central
region of mouse retinae 1 and 3 days post-light treatment
(Figures 1A,B,D,E,F). Overall cell loss was indicated by a reduced
number of DAPI-positive cells in the ONL after both light
treatments (Figures 1A,B,D,E,G). Reactivity of retinal cells to
light stimuli was proven by increased expression levels of LD
marker lif1 and gfap in the retina 1 and 3 days post-light-
treatment (Supplementary Figures S1D–F).
Complement Factors Were Locally
Expressed in the Untreated Albino
Mouse Eye
The aim of the study was to evaluate the role of the local
complement system in LD. First, we compared complement
factor expression on mRNA and protein level in the retina
and RPE/choroid of untreated control albino mice (Table 1).
Complement factors c1s, cfb, c3, c4 and cfp mRNA were
constantly expressed in the retina and RPE/choroid of untreated
Balb/c mice (Table 1). We determined a significantly higher
expression level for c1s and c3 mRNA in the RPE/choroid
compared to the retina (Table 1) and vice versa a higher
expression of cfp mRNA in the retina than in the RPE/choroid
(Table 1). There was no significant difference in the tissue-specific
expression of cfb and c4 in the eye (Table 1). C9 mRNA and
complement factors of the lectin pathway, mbl-a and masp-1,
were detected only in a few animals of the control group (Table 1
and Figures 2, 3).
All tested complement factors were found on protein level
in the RPE/choroid (Table 1). In general, the retina was less
positive for complement deposition than the RPE/choroid as
we observed no CFB or C4 protein and low C3 protein
levels in the untreated retina (Table 1 and Figures 4–6).
The increased tissue-specific mRNA expression for c3 in the
RPE/choroid (Table 1) was confirmed by increased protein
detection in Western blots (Table 1 and Figures 4C, 6D) and
immunohistochemistry (Figure 5). Higher molecular weight
complexes containing either C1s or C9 showed also a 4–5-fold
enhanced protein detection signal in the RPE/choroid than in
the retina (Table 1, Figures 4A,D, 6A,F, and Supplementary
Figures S6A,B, S7D,E).
White Light Increased c1s, cfb, c3, and
c4 Expression in the Retina Dependent
on the Recovery Time, But Decreased
cfp and c9 Expression
Complement activation was previously described as a cause for
LD (Rohrer et al., 2007; Rutar et al., 2011). We asked the
question, whether there is a difference in complement factor
expression following constant (1000 lux, 24 h) or acute (5000 lux,
0.5 h) LD in the eye (Figures 2, 3). We identified a significant
increase of c1s, cfb, c3 and c4 mRNA expression in the retina
following both light treatment regimens (Figures 2A,B,E,F).
Interestingly, there was a difference in the reaction regarding the
recovery time after light treatment. Mice treated with 1000 lux
for 24 h (constant) showed an enhanced complement gene
expression in the retina after 1 day recovery (Figure 2, white
bars), which correlated with the time-dependent apoptosis in the
ONL (Figure 1F). In contrast, mice treated with 5000 lux for
0.5 h (acute) showed a change in c1s, cfb, c3 and c4 expression in
the retina mainly 3 days after light illumination (Figure 2, black
bars).
The terminal complement factor c9 and the alternative cascade
stabilizer cfp were constantly expressed in the healthy retina
(Table 1), but the expression signals were decreased in the
light treated animals (Figures 2G,H). Cfp mRNA expression was
promptly regulated and a significant change was detected as early
as 1 day post-treatment in both models (Figure 2H).
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FIGURE 2 | Retinal transcription of complement factors changed dependent on the recovery time after different light treatment regimens. mRNA expression was
analyzed in the retinae of mice treated either with constant (1000 lux, 24 h; white bars) or acute white light (5000 lux, 0.5 h; black bars) and compared to untreated
controls. (A) c1s, (B) cfb, (C) mbl-a, (D) masp-1, (E) c3, (F) c4, (G) c9, and (H) cfp mRNA was determined. (A) C1s, (B) cfb, (E) c3, and (F) c4 mRNA was
significantly elevated either at 1 day following constant (white column) or at 3 days following acute (black column) light treatment. (G,H) C9 and cfp mRNA
expression was decreased following LD. Data represent mean values + standard error of the mean. (C) mbl-a, (D) masp-1 and (G) c9 mRNA was partly detected.
Positive animals were indicated as small numbers in the bars. Mean of untreated control shown as dotted line. ∗0.01 < P < 0.05, ∗∗0.001 < P < 0.01, ∗∗∗0.0001
< P < 0.001, and ∗∗∗∗P < 0.0001 (ordinary one-way ANOVA, Dunnett’s multiple comparisons test, with a single pooled variance).
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FIGURE 3 | mRNA expression of complement factors in the RPE/choroid-complex is increased at 1 day following constant and acute LD. mRNA expression was
analyzed in the RPE/choroid of mice treated either with constant (1000 lux, 24 h; white bars) or acute white light (5000 lux, 0.5 h; black bars) and compared to
untreated controls. (A) c1s, (B) cfb, (C) mbl-a, (D) masp-1, (E) c3, (F) c4, (G) c9, and (H) cfp mRNA was determined. (A) C1s, (B) cfb, (E) c3, (F) c4, and (G) c9
mRNA was elevated at 1 day post-light treatment. mRNA expression decreased 3 days following LD. (C) mbl-a and (G) c9 mRNA was partly detected. Positive
animals were indicated as small numbers in the bars. Data represent mean values + standard error of the mean. Mean of untreated control shown as dotted line.
∗0.01 < P < 0.05, ∗∗∗0.0001 < P < 0.001, ∗∗∗∗P < 0.0001 (ordinary one-way ANOVA, Dunnett’s multiple comparisons test, with a single pooled variance).
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FIGURE 4 | Complement protein expression in the retina showed increased C3 deposition after LD. Complement protein expression of (A) C1s (see also
Supplementary Figure S6A), (B) MBL (see also Supplementary Figure S6C), (C) C3 (see also Supplementary Figure S6D), (D) C9 (see also Supplementary
Figure S6B) and (E) CFP (see also Supplementary Figure S6E) in the retinae of mice either treated with constant (1000 lux, 24 h; white bars) or acute white light
(5000 lux, 0.5 h; black bars) was compared to untreated controls (gray bars) in Western blot. (B,C) Stacked bars correspond to different molecular weights of protein
fragments. Data represent mean percentages of the GAPDH control signal of 4–6 mice of each treatment group. Exemplarily Western blots are shown for
complement protein detection in one mouse tissue, respectively (for entire blots see Supplementary Figure S6). Blots were sequentially developed (Supplementary
Figure S4). CFB and C4 were not detected in retinae. ∗0.01 < P < 0.05 (ordinary one-way ANOVA, Dunnett’s multiple comparisons test, with a single pooled
variance).
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FIGURE 5 | Reactive Müller cells, astrocytes and RPE are co-localized with C3d in LD retinae. Immunolabelled mouse eye sections for C3d (red) and GFAP (green)
showed a LD-dependent Müller cell and astrocyte activation (GFAP, green) as well as complement activation (C3d, red), irrespective of light intensity and recovery
time. (A) Untreated mouse retinae were negative for gliosis and showed a distinct C3d-dependent staining of Bruch’s membrane. (B–E) Retinae treated with bright
light depicted an increased GFAP-staining of Müller cells and astrocytes which was partly co-localized with C3d staining in the retina. C3d staining at the
RPE/Bruch’s membrane was increased after light treatment and additionally deposited at the surface of RPE cells. Retinal layers from the top to the bottom: GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRS, photoreceptor segments; RPE,
retinal pigment epithelium; BM, Bruch’s membrane; Ch, choroid. Scale bars, 20 µm.
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FIGURE 6 | Increased C1s-complex and decreased C9-complex deposition in the RPE/choroid after LD. Complement protein expression of (A) C1s (see also
Supplementary Figure S7D), (B) CFB (see also Supplementary Figure S7C), (C) MBL (see also Supplementary Figure S7F), (D) C3 (see also Supplementary
Figure S7A), (E) C4 (see also Supplementary Figure S7H), (F) C9 (see also Supplementary Figure S7E), and (G) CFP (see also Supplementary Figure S7G) in the
RPE/choroid of mice either treated with constant (1000 lux, 24 h; white bars) or acute white light (5000 lux, 0.5 h; black bars) was compared to untreated controls
(gray bars) in Western blot. (A,D) Stacked bars correspond to different molecular weights of protein fragments. Data represent mean percentages of the GAPDH
control signal of 4–6 mice of each treatment group. Exemplarily Western blots are shown for complement protein detection in one mouse tissue, respectively (for
entire blots see Supplementary Figure S7). Blots were sequentially developed (Supplementary Figure S4). ∗∗0.001 < P < 0.01 (ordinary one-way ANOVA, Dunnett’s
multiple comparisons test, with a single pooled variance).
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FIGURE 7 | Microglia/macrophage cells migrate at 1 day after LD in the ONL and at 3 days in the PRS. Immunoreactivity for Iba-1 (green) showed
microglia/macrophage distribution in (A) an untreated mouse retina, (B,C) retinae treated with 1000 lux for 24 h and (D,E) retinae illuminated with 5000 lux for 0.5 h.
(B,D) Mice showed microglia/macrophage migration into the ONL at 1 day post-LD (white arrows). (C,E) Three days post-light treatment microglia/macrophages
were located in the ONL (white arrows) and additionally in the PRS (black arrows) in both light treatment regimens. Retinal layers from the top to the bottom: GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRS, photoreceptor segments; RPE,
retinal pigment epithelium; Ch, choroid. Scale bars, 20 µm.
FIGURE 8 | Systemic C3a and C5a concentrations were altered in LD mice. Anaphylatoxin concentrations, (A) C3a and (B) C5a, in sera of mice treated with white
light were determined in ELISA. (A) C3a and (B) C5a concentrations were elevated compared to the control group, but showed a wide concentration range and
standard error within the groups. (A) Systemic C3a concentration in mice was significantly increased 1 day post-constant light treatment (1000 lux, 24 h). Data
represent mean values + standard error mean of six mice. ∗0.01 < P < 0.05 (ordinary one-way ANOVA, Dunnett’s multiple comparisons test, with a single pooled
variance).
Complement Factor Expression in the
RPE/Choroid Changed Independently
from the Light Intensity and Increased at
1 Day But Decreased at 3 Days Post-LD
The complement factor mRNA expression in the RPE/choroid
correlated in the constant light (1000 lux, 24 h) treated animals,
for most of the analyzed factors (exception: c9, cfp), with the
retinal expression pattern (white bars, Figures 2, 3). We observed
a significant increase of mRNA for cfb and c4 (Figures 3B,F) as
well as an elevated signal for c1s, c3 and c9 at 1 day compared to
3 days post-LD (Figures 3A,E,G). The mice treated with acute
light (5000 lux, 0.5 h) showed a comparable expression as the
constant light treated animals in the RPE/choroid (Figure 3).
This was in contrast to the retinal expression pattern in the
acute group, where we observed an increased mRNA expression
only 3 days after LD but not immediately 1 day post-LD
(black bars, Figures 2, 3). The complement factor expression in
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the RPE/choroid decreased at 3 days post-LD in both models
(Figure 3). We emphasize that the gene expression levels for
cfb and c3 even dropped below the normal expression levels of
untreated mice (Figures 3B,E).
Similar Regulation of Complement
Factors at mRNA Levels in Acute and
Constant LD
The described complement gene expression studies (Figures 2, 3)
suggested a pattern for the regulation of complement gene
expression following LD. Indeed, when we plotted the gene
expression profiles of all tested genes in one graph corresponding
to the used light intensities and tested tissues (Supplementary
Figure S3), we found two different mRNA expression profiles. On
the one hand, a similar expression pattern in the RPE/choroid
complex following constant (1000 lux, 24 h) and acute
(5000 lux, 0.5 h) LD as well as in the retina after constant
LD (Supplementary Figures S3A,C,D): Complement mRNA
expression decreased from 1 day recovery to 3 days recovery. On
the other hand, this progress of complement expression appeared
to lag behind in the retinae of animals treated with 5000 lux
(Supplementary Figure S3B): All complement factors (except cfb)
showed no change in expression level after 1 day recovery in mice
treated with 5000 lux compared to the control group. However,
in contrast to the 1000 lux treated animals the mice showed an
increase of complement expression in the retina at 3 days (except
c9) (Supplementary Figure S3B).
C3 Deposition Was Increased after LD
Further, we investigated if the mRNA expression of complement
genes corresponded to protein detection in the eye (Figures 4–6
and Supplementary Figures S4, S6, S7). The only significant
changes in the retina after light treatment were observed in
regard to C3-the central complement protein (Figures 4C, 5
and Supplementary Figure S6D). C3 protein concentrations were
elevated in all light-treated mice retinae compared to the control
in Western blots, irrespectively of the recovery time (Figure 4C
and Supplementary Figure S6D). C3d deposition, which is a
cleavage product of C3b, was also increased in immunostainings
of tissue sections following acute and constant LD (Figure 5).
C3d-staining in the LD-retinae co-localized with GFAP-reactive
Müller cells and astrocytes (Figure 5). The increased C3 protein
detection in the retina correlated with increased c3 mRNA
expression in the retina after LD (Figure 2E), except that the
c3-transcription level in the acute model did not change after
1 day recovery (Figure 2E).
The trend for diminished c3 mRNA expression in the
RPE/choroid complex 3 days after constant and acute
LD (Figure 3E) corresponded to decreased C3 protein
detection in Western blots in the RPE/choroid (Figure 6D
and Supplementary Figure S7A). Especially, the C3-alpha chain
fragment (45 kDa) was missing after 3 days in the RPE/choroid-
complex (Figure 6D and Supplementary Figure S7A). In
contrast, we observed an increased C3d immunostaining in
the RPE/choroid after LD (Figures 5B–E). C3d was deposited
at the surface of the RPE-cells following both light regimens
(Figures 5B–E). The differences in C3d-detection in Western
Blots and immunostainings could be explained by the different
specificities and affinities of the antibodies used here: the anti-C3
antibody in the Western Blots detected C3 irrespective of its
activation pattern (Figure 6D and Supplementary Figure S7A)
and in the immunostaining the antibody showed a selective
specificity against the C3d activation product (Figure 5).
Classical Complement Pathway Initiator
C1s-Protein Complex Accumulated in
RPE/Choroid after LD
C1s is a protease, which acts in a high molecular weight
protein complex with C1r and C1q. Western blots from the
RPE/choroid of LD mice showed a significant increase of the C1s-
complex (140 kDa) 3 days post-light treatment (Figure 6A and
Supplementary Figure S7D). The 2-times higher C1s-complex
signal in the RPE/choroid did not completely overlap with an
elevated local c1s mRNA expression following light-treatment but
could be a result of a delayed increase of C1s protein expression
compared to its transcript in the retina and RPE/choroid at 1 day
after constant and acute light illumination (Figures 2A, 3A). We
did not observe a change in C1s protein deposition in the retina
(Figure 4A and Supplementary Figure S6A).
LD Resulted in Reduced Soluble
C9-Complex Concentrations in the
RPE/Choroid and Increased C5b-C9
Deposition in the Retina
C9 is the central protein of the terminal pathway of the
complement system and forms the membrane attack complex
together with C5b-C8. Soluble C9 protein detection in untreated
mice was 4-fold higher in the RPE/choroid than in retina
(Table 1, Figures 4D, 6F, and Supplementary Figures S6B, S7E).
LD resulted in decreased soluble C9 levels at 3 days in the
RPE/choroid in both treatment regimens compared to the control
(Figure 6F and Supplementary Figure S7E). This correlated
with decreased c9 mRNA expression in the RPE/choroid
following constant and acute white light-treatment after 3 days
recovery (Figure 3G). While the concentration of the terminal
complement membrane attack complex, consisting of C5b-C9,
was enhanced after light-treatment in the retinae (Supplementary
Figure S5).
Müller Cells, Astrocytes, and
Microglia/Macrophages Were Activated
1 Day after Light Treatment
Next we asked the question whether the local, time dependent
expression of complement factors after LD is associated with local
cellular activity. Hence, the activity of Müller cells and astrocytes
(Figure 5) as well as the migration of microglia/macrophages was
assessed by immunostaining (Figure 7). GFAP-staining (a marker
for gliosis) showed reactive Müller cells and astrocytes in all mice
at 1 and 3 days after light treatment (Figure 5), but not in the
untreated animals. It is of note that a co-localization of C3d and
GFAP was observed in the light treated mouse retinae (Figure 5).
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Iba-1 positive cells (a marker for microglia/macrophages)
were sparsely localized in the plexiform layers and in the choroid
of untreated mice (Figure 7A). A moderate recruitment of
amoeboid microglia/macrophages into the ONL was observed
after light treatment in both light regimens (white arrows,
Figures 7B–D). An extended recovery time of 3 days after
LD promoted microglia/macrophage migration into the
photoreceptor layer (PRS) (black arrows, Figures 7C,E). We did
not observe an obvious difference in the microglia/macrophage
reaction pattern using constant or acute white light treatment.
LD Resulted in Increased Systemic C3a
and C5a Concentrations
The interaction of local and systemic complement system in
retinal degeneration is still under debate. We evaluated systemic
complement involvement in mice after LD by determining serum
concentrations of C3a and C5a, which are activation markers
for all three complement pathways (Figure 8). The systemic
reaction toward light treatment was very heterogeneous. We
observed a partial increase of anaphylatoxin concentrations, but
not in all animals, following LD (Figure 8). We identified a
significant increase of C3a concentration after 1 day of constant
light treatment (1000 lux, 24 h) (Figure 8A).
DISCUSSION
Complement Factors Are Locally
Expressed in the Healthy, Albino Mouse
Retina
Dysregulation of the complement system in the eye is associated
with retinal degeneration and damage of the blood-retinal barrier
(Weber et al., 2014). However, we are still confronted with a
chicken and egg problem in regard to retinal degeneration. At
what time is which player activating the complement cascade in
the eye? Is the systemic complement system involved, which is
produced in the liver or by immune cells and then transported by
the blood into the choroid? Or is the damage of the retinal blood
barrier associated with locally produced complement factors
by RPE cells and retinal cells? Successful treatment strategies
for retinal degeneration depend on an effective on-site drug
application and therefore our knowledge about regional and
temporal complement involvement needs to be extended (Volz
and Pauly, 2015).
In this study, we focused on eye tissue specific complement
factor analysis, dissecting the retina from the RPE/choroid. In
accordance with the literature we showed, that c3 and c1s mRNA
were mainly expressed in the RPE/choroid of healthy albino
mouse eyes (Luo et al., 2011; Gemenetzi and Lotery, 2015).
Conversely, cfp mRNA was expressed at higher amounts in the
retina and the local expression levels of cfb, c4 and c9 mRNA were
equivalent in both eye tissues (Luo et al., 2013; Woodell et al.,
2013). In contrast, genes involved in the lectin pathway, mbl-a
and masp-1, were only detected in a few control mice in retinal
and RPE/choroid samples. Lou et al. described also a lack of mbl
and low masp expression in the mouse eye (Luo et al., 2011).
The tested complement factors in this study were soluble,
secreted proteins which were deposited and acted independently
of their mRNA synthesis site. A tissue-specific correlation of
mRNA detection and protein deposition revealed only for C3
and MASP-1 an overlap of similar, local mRNA and protein
levels. However, we detected enhanced mRNA levels for c1s
in the RPE/choroid but more C1s protein in the retina than
in the RPE/choroid. Additionally, we determined an equivalent
expression of cfb, c4, and c9 mRNA in both tissues, but an
enhanced tissue-specific protein detection either in the retina for
CFB and C4 or in the RPE/choroid for C9.
In summary, we conclude that complement factors are
produced by healthy eye tissues on mRNA and protein level.
Therefore, local complement expression could play an important
role in the modulation of the complement homeostasis in the
mouse eye and should be evaluated in parallel on mRNA levels
as well as on protein levels. Care has to be taken when concluding
from immunolocalization of respective complement proteins to
the cell types actually producing the proteins given their features
as secreted proteins.
Complement Expression Is
Time-Dependently Altered in the Murine
Eye as a Consequence of LD
Rohrer et al. (2007), Rutar et al. (2011), Hadziahmetovic et al.
(2012), and Song et al. (2012) suggested an involvement of the
complement system in the degenerative processes in LD and
described an upregulation of c3 mRNA expression 3 h after
LD and with a plateau at d4–10 post-LD. We confirmed these
results, describing a statistically significant difference in c3 mRNA
expression at 1 day after constant and 3 days after acute light
treatment compared to untreated animals (Figure 2E). These
previous studies did not report a decrease of c3 mRNA expression
at 3 days post-LD (Rohrer et al., 2007; Rutar et al., 2011),
which was characteristic for the studied mRNA expression in
the constant and acute LD models in the RPE/choroid and the
constant model in the retina (Figures 2E, 3E and Supplementary
Figure S3). Likely reasons for the differences could be that in
the study by Rohrer et al. (2007) the mice were treated with
continuous white light without a low light recovery phase and in
our study light treatment was used as a trigger mechanism for a
maximum of 24 h. Rutar et al. (2011) used rats for LD. Perhaps
LD-dependent complement expression is different in murine and
rat retina. This hypothesis is supported by novel data of the
same group showing, that for pigmented light treated mice c3
mRNA expression decreases after a peak expression at d5 again
in contrast to c3 expression in rats (Rutar et al., 2011; Natoli et al.,
2016)
Additionally to the central complement component C3, we
report a tissue- and LD model-dependent increase of C1s
mRNA and protein after LD (Figures 2A, 3A, 4A, 6A and
Supplementary Figures S6A, S7D). The upregulation of this
classical pathway activation factor was also described previously
for LD in rats (Rutar et al., 2011). We emphasized the function
of C1s in LD by showing for the first time an elevated C1s-
protein complex accumulation in the RPE/choroid complex
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after LD (Figure 6A and Supplementary Figure S7D). C1s is a
protease which acts in concert with C1q and C1r and cleaves
components of the classical complement pathway. This could
implicate an involvement of the classical complement pathway
at the retinal-blood-barrier after LD. It was already proposed
that the C1 complex could be involved in retinal degeneration,
since a single nucleotide polymorphism in the C1-inhibitor is
associated with AMD (Ennis et al., 2008). However, a deficiency
in C1q did not result in a significant difference of retinal
structure following LD compared to wild-type mice (Rohrer et al.,
2007).
The possible involvement of the classical (C1s) pathway
in LD requires the activity of molecules downstream of the
activation step to execute the full biological function of the
complement system in LD. We showed in accordance with
previous reports, that c4 mRNA, a part of the classical/lectin
C3/C5-convertase, is upregulated in the retina and RPE/choroid
following LD (Figures 2F, 3F; Rohrer et al., 2007; Rutar et al.,
2011), but we could not correlate changes on protein level for
C4 (Figure 6E and Supplementary Figure S7H), probably due
to antibody detection problems. Nevertheless, this complement
component should be further studied in retinal degeneration,
especially in regard to the complexity of the c4 gene locus
and the association of copy number variations of the C4A
gene in different disease (Grassmann et al., 2016; Sekar et al.,
2016).
Interestingly, Rohrer et al. (2007) suggested an important role
of the alternative complement pathway in LD as photoreceptors
of complement factor D-deficient mice were significantly
protected from LD. The important function of the alternative
pathway in retinal degeneration was also shown in CFB-
deficient mice, which were protected from retinal degeneration
by laser-induced choroidal neovascularization and cigarette
smoke exposure (Woodell et al., 2013; Schnabolk et al.,
2015). We showed in accordance with these studies that
cfb mRNA is strongly and promptly upregulated in the
RPE/choroid and in the retina after LD, this promotes the
role of CFB and the alternative pathway in LD (Figures 2B,
3B), while we did not observe CFB protein deposition in
the retina and no change in the RPE/choroid with the used
antibodies (Figure 6B and Supplementary Figure S7C). CFB
is cleaved into Bb and Ba during complement activation.
Therefore, further studies analyzing the function of CFB in
retinal damage should focus on the detection of the CFB
cleavage products, Bb and Ba, in the retina to elucidate
our reported discrepancy between enhanced cfb mRNA
expression and the uncorrelated CFB full-length protein
detection.
The lectin pathway is the third complement activation
mechanism of the complement system and microarray studies
showed a changed expression for ficolin, an initiating molecule
of the lectin pathway, in rats after LD (Rutar et al., 2011). Our
studies revealed a low expression of mbl-a and masp-1 after LD
(Table 1, Supplementary Figure S2, and Figures 2C,D, 3C,D)
and no significant change either on protein or on mRNA levels
(Figures 4B, 6C and Supplementary Figures S6C, S7F). However,
a participation of the lectin pathway in retinal degeneration
was proposed as it was shown that MBL and MASP-1 were
systemically upregulated in late AMD-patients (Osthoff et al.,
2015; Kim et al., 2016). Taking our results into account, it seems
that previously reported effects of the lectin pathway on RPE cells
and in a laser-induced neovascularization mouse model are either
supported by systemic MBL and MASP or other lectin activating
molecules like ficolin, than by locally expressed mbl-a and masp-1
(Rohrer et al., 2011; Joseph et al., 2013).
In context of complement profiling in LD, we also aimed
to analyze the role of C9, the main component of the
terminal complement complex. C9 had been proposed to
be relevant in laser-induced choroidal neovascularization in
mice (Rohrer et al., 2011; Birke et al., 2014) and had been
associated with the development of AMD (Wang et al., 2010;
Seddon et al., 2013). Surprisingly, the transcription of the
c9 gene was, besides cfp, the only complement gene which
was downregulated after LD in the retina, but immediately
upregulated in the RPE/choroid (Figures 2G, 3G). This is
in accordance with previously shown increased deposition of
terminal complement complexes at the RPE/choroid interface
in mice and human age-related retinal modifications (Tomita
et al., 2005; Izawa et al., 2016; Niwa et al., 2016), but it
is contrary to the decreasing protein concentration of C9 in
the RPE/choroid determined by Western blots in this study
(Figure 6F and Supplementary Figure S7E). We suggest that
the enhanced c9 mRNA synthesis in the RPE/choroid following
LD resulted in higher concentrations of C9 protein, which was
immediately integrated into membrane pores (Supplementary
Figures S5C–E) and could not be purified and detected
in the used Western blot protocol (Figures 4D, 6F and
Supplementary Figures S6B, S7E). Therefore, the soluble C9
protein concentration was decreased following LD, but the
membrane associated C9 concentration was increased after
retinal damage (Tomita et al., 2005; Izawa et al., 2016; Niwa et al.,
2016).
Complement activity is tightly regulated by membrane-bound
and soluble complement factors. We assumed that the expression
of CFP, the only known stabilizing regulator of the alternative
complement pathway, would also be altered in LD. Surprisingly,
cfp mRNA expression was not upregulated after LD like other
tested complement factors (Figures 2H, 3H). Cfp expression has
not been evaluated in previous LD studies. Indeed, cfp expression
has been shown to be quite stable in vivo and in vitro in response
to several stimuli such as preeclampsia or renal tubular damage
(Reis et al., 2006; Buurma et al., 2012; Nagamachi et al., 2014),
while it has been described to be upregulated following shear
stress in endothelium (Bongrazio et al., 2003). However, our
results do not automatically imply, that CFP is not involved in
degeneration, as we know from other studies that CFP deposition
was positive in patient eyes with AMD (Wolf-Schnurrbusch
et al., 2009) and was associated with drusen-like deposition in
Alzheimer’s disease (Fonseca et al., 2011). Further studies have to
be performed to decipher the expression pattern of CFP in more
detail.
Interestingly, the activation pattern of the complement system
(at protein level) mirrors the glial activation pattern. Similar
to increasing C3 and C1s protein levels from 1 to 3 days
Frontiers in Molecular Neuroscience | www.frontiersin.org 14 June 2017 | Volume 10 | Article 197
fnmol-10-00197 June 16, 2017 Time: 14:1 # 15
Schäfer et al. Local Complement in Retinal Degeneration
post-treatment, the microglia/macrophages migrated into the
subretinal space and got into close contact with photoreceptor
segments 3 days after LD. Moreover C3d deposition on
GFAP-positive Müller glia cells was only observed in retinae
3 days after LD. Specifically microglia/macrophages are known
to express receptors for complement factors such as C3a (Rutar
et al., 2011). In sum, this could imply that the complement
activity by binding on Müller cells (e.g., C3b or C3d levels)
triggers or modulates the microglial (e.g., C3a) response pattern
upon tissue damage. This finding should be followed up in future
studies.
CONCLUSION
Our results indicate a time-dependent and tissue-specific
complement modulation in close association with LD in albino
mice eyes which was mostly independent of the used light
intensities. In the end, the complement proteins C3, C1s and C9
were identified as putative marker proteins in the LD model to
monitor disease progression, as they showed valid concentration
changes in a time-dependent manner compared to control mice
(Figures 4C, 6A,F and Supplementary Figures S6D, S7D,E). The
most significant alterations in complement protein concentration
in the retina (C3) and RPE/choroid-complex (C9, C1s) after
LD were observed 3 days post-treatment. The proteins were
regulated in different ways: C3 and C1s were increased, but C9
was downregulated. This may indicate different functions of the
proteins during retinal degeneration that need to be investigated
in future studies.
Complement expression is time-dependently regulated after
the initiation of cell stress in the retina and RPE/choroid.
This also implies that one should monitor the eye-
specific complement expression pattern after damage, when
complement-manipulating reagents are tested for therapeutic
reasons in the mouse eye.
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